Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AC Immune SA - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ACIU
Nasdaq
8731
https://www.acimmune.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AC Immune SA
Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%
- Mar 15th, 2024 10:19 am
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
- Mar 14th, 2024 11:00 am
AC Immune Announces Upcoming Presentations at AD/PD™ 2024
- Feb 22nd, 2024 12:00 pm
AbbVie (ABBV) Announces Appointment of New CEO Robert Michael
- Feb 21st, 2024 3:43 pm
Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround
- Jan 30th, 2024 2:35 pm
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
- Jan 22nd, 2024 12:00 pm
AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?
- Jan 18th, 2024 5:00 pm
5 Small-Cap Stocks to Play the January Effect
- Jan 8th, 2024 2:59 pm
AC Immune (ACIU) Upgraded to Buy: Here's Why
- Jan 3rd, 2024 5:00 pm
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
- Jan 3rd, 2024 1:10 pm
AC Immune Announces Pricing of Underwritten Offering of Common Shares
- Dec 15th, 2023 12:56 pm
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
- Dec 15th, 2023 12:22 pm
AC Immune SA's (NASDAQ:ACIU) top owners are private equity firms with 37% stake, while 25% is held by individual investors
- Dec 13th, 2023 10:42 am
The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity
- Dec 12th, 2023 2:10 pm
Alzheimer's Disease Space Evolves in 2023: Stocks in Focus
- Dec 11th, 2023 2:06 pm
Is it a Good Idea to Invest in AC Immune (ACIU) Stock Now?
- Dec 5th, 2023 10:59 am
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
- Dec 1st, 2023 12:00 pm
Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
- Nov 29th, 2023 12:33 am
Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?
- Nov 27th, 2023 2:40 pm
FOCUS-Researchers return to Alzheimer's vaccines, buoyed by recent drug success
- Nov 20th, 2023 11:00 am
Scroll